Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Weight Loss and EGFR[original query] |
|---|
| Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation. Nature clinical practice. Oncology 2006 1 3 (1): 50-7; quiz 1 p following 57. Choong Nicholas W, Dietrich Sascha, Seiwert Tanguy Y, Tretiakova Maria S, Nallasura Vidya, Davies Gareth C, Lipkowitz Stanley, Husain Aliya N, Salgia Ravi, Ma Patrick |
| Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1382-90. Ready Neal, Jänne Pasi A, Bogart Jeffrey, Dipetrillo Thomas, Garst Jennifer, Graziano Stephen, Gu Lin, Wang Xiaofei, Green Mark R, Vokes Everett E, |
| Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene. Oncology reports 2013 Sep 30 (3): 1463-72. Krawczyk Pawe?, Kowalski Dariusz M, Krawczyk Kamila Wojas, Szczyrek Micha?, Mlak Rados?aw, Rolski Andrzej, Szudy Aneta, Kieszko Robert, Winiarczyk Kinga, Milanowski Janusz, Krzakowski Maci |
| AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients. Molecular cancer therapeutics 2016 Aug . Xu Xiao, Mao Long, Xu Wanhong, Tang Wei, Zhang Xiaoying, Xi Biao, Xu Rongda, Fang Xin, Liu Jia, Fang Ce, Zhao Li, Wang Xiaobo, Jiang Ji, Hu Pei, Zhao Hongyun, Zhang |
| Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 5 13 (9): 1363-1372. Gettinger Scott, Hellmann Matthew D, Chow Laura Q M, Borghaei Hossein, Antonia Scott, Brahmer Julie R, Goldman Jonathan W, Gerber David E, Juergens Rosalyn A, Shepherd Frances A, Laurie Scott A, Young Tina C, Li Xuemei, Geese William J, Rizvi Naiy |
| Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI. Journal of Cancer 2018 9 (3): 528-534. Lin Liping, Zhao Juanjuan, Hu Jiazhu, Huang Fuxi, Han Jianjun, He Yan, Cao Xiaolo |
| Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study. Journal of thoracic disease 2017 Dec 9 (12): 5068-5074. Shen Qian, Dong Xiaoqi, Tang Xiaoping, Zhou Jianyi |
| Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients. Clinical nutrition (Edinburgh, Scotland) 2019 8 39 (6): 1893-1899. Jouinot Anne, Ulmann Guillaume, Vazeille Clara, Durand Jean-Philippe, Boudou-Rouquette Pascaline, Arrondeau Jennifer, Tlemsani Camille, Fournel Ludovic, Alifano Marco, Wislez Marie, Chapron Jeanne, Le Bris Camille, Mansuet-Lupo Audrey, Damotte Diane, Neveux Nathalie, De Bandt Jean-Pascal, Alexandre Jérôme, Cynober Luc, Goldwasser Franço |
| Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients. Respiratory medicine and research 2019 Oct 77 46-54. Molinier O, Goupil F, Debieuvre D, Auliac J-B, Jeandeau S, Lacroix S, Martin F, Grivaux |
| Patient-Generated Subjective Global Assessment (PG-SGA) predicts length of hospital stay in lung adenocarcinoma patients. The British journal of nutrition 2021 9 127 (10): 1543-1548. Lang Jilu, Shao Yanan, Liao Jiehao, Chen Jia, Zhou Xuewen, Deng Rong, Wang Wei-Jan, Sun Xi |
| Influence of loneliness and social isolation on the diagnosis and treatment of Japanese patients with advanced lung cancer: a prospective cohort study. Annals of palliative medicine 2021 6 10 (6): 6236-6246. Takemura Tomoyasu, Kataoka Yuki, Shirakawa Chigusa, Okazaki Koya, Sakurai Azusa, Imakita Takuma, Ikegaki Shunkichi, Matsumoto Hirotaka, Saito Emiko, Takata Hirohito, Kaku Sawako, Wada Nobuko, Shinomiya Mariko, Otoshi Takehiro, Shimada Masatoshi, Nikaido Junichi, Iki Reika, Hirano Katsuya, Hirai Tomoyuki, Endo Kazuo, Hirabayashi Masataka, Naganuma To |
| Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation. Nutrients 2021 Oct 13 (11): . Chen Yu-Mu, Lai Chien-Hao, Lin Chiung-Yu, Tsai Yi-Hsuan, Chang Ya-Chun, Chen Hung-Chen, Tseng Chia-Cheng, Chang Huang-Chih, Huang Kuo-Tung, Chen Yung-Che, Fang Wen-Feng, Wang Chin-Chou, Chao Tung-Ying, Lin Meng-Ch |
| Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity. Metabolism: clinical and experimental 2022 Jun 133 155237. Valenzuela-Vallejo Laura, Chrysafi Pavlina, Bello-Ramos Jenny, Bsata Shahd, Mantzoros Christos |
| Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer. ERJ open research 2022 10 8 (4): . Gijtenbeek Rolof G P, van der Noort Vincent, Aerts Joachim G J V, Staal-van den Brekel Jeske A, Smit Egbert F, Krouwels Frans H, Wilschut Frank A, Hiltermann T Jeroen N, Timens Wim, Schuuring Ed, Janssen Joost D J, Goosens Martijn, van den Berg Paul M, de Langen A Joop, Stigt Jos A, van den Borne Ben E E M, Groen Harry J M, van Geffen Wouter H, van der Wekken Anthonie |
| Efficacy and safety of 40?mg osimertinib administered every other day for non-small cell lung cancer harboring an epidermal growth factor receptor mutation: A single-center retrospective cohort study. Thoracic cancer 2024 1 . Ayumu Otsuki, Naoki Inoshima, Kentaro Tochigi, Hiroyuki Ito, Kei Nakashi |
- Page last reviewed:Feb 1, 2024
- Content source: